Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Diabetic Peripheral Neuropathy

NCT00380913 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathies

Interventions

DRUG: Cesamet™ (nabilone)

Sponsor

NEMA Research, Inc.